Proof of concept trial of levodopa-deuterated (SD 1077)

Trial Profile

Proof of concept trial of levodopa-deuterated (SD 1077)

Planning
Phase of Trial: Phase II

Latest Information Update: 05 May 2015

At a glance

  • Drugs Levodopa deuterated (Primary)
  • Indications Parkinson's disease
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Auspex Pharmaceuticals
  • Most Recent Events

    • 27 Jan 2015 New trial record
    • 12 Jan 2015 This trial is expected to be initiated and data reported in 2016, according to an Auspex Pharmaceuticals media release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top